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Abstract
Background: The aim of this study is to investigate cerebral endothelial dysfunction in patients with reversible
cerebral vasoconstriction syndrome (RCVS).
Methods: We prospectively recruited patients with RCVS, age-matched controls with episodic migraine, and
age-matched healthy controls at Samsung Medical Center from Apr 2015 to Jul 2016. All participants underwent
transcranial Doppler evaluation, with a breath-holding maneuver, for the evaluation of bilateral middle cerebral
arteries (MCAs), posterior cerebral arteries (PCAs), and the basilar artery (BA). The breath-holding index (BHI) was
used to measure cerebral endothelium-dependent vasodilation. Follow-up BHIs were recorded in selected patients
with RCVS after 3 months.
Results: A total of 84 subjects were recruited for this study (n = 28 in each group of RCVS, episodic migraine, and
healthy control; mean age, 49.8 years). The RCVS group showed lower BHIs in all basal arteries, in comparison to
healthy controls (p < 0.001, 0.009 for bilateral MCAs, p < 0.001 and 0.028 for bilateral PCAs, and p = 0.060 for the BA).
Compared to migraineurs, RCVS patients had lower BHIs only in the anterior circulation (p = 0.002 and 0.038 for
bilateral MCAs; p = 0.069 and 0.247 for bilateral PCAs; p = 0.120 for the BA). Of the 10 patients who had follow-up
BHIs at 3 months, 7 showed complete normalization, while three did not.
Conclusions: Cerebral endothelial function is impaired in a widespread distribution in RCVS. Its role in the
pathogenesis and clinical outcome of RCVS should be determined in further studies.
Keywords: Reversible cerebral vasoconstriction syndrome, Pathophysiology, Endothelial dysfunction, Breath holding
index, Cerebral vasomotor reactivity
Background
Reversible cerebral vasoconstriction syndrome (RCVS) is
characterized by reversible multifocal narrowing of the
cerebral arteries with typical manifestations of recurrent
thunderclap headache with or without focal neurologic
deficits [1]. In patients with RCVS, thunderclap head-
ache is often triggered by the Valsalva maneuver or
emotional stress, implicating a dysregulation of cerebral
arterial tone with increased sympathetic stimuli.
The mechanism of RCVS is not fully understood. To
date, abnormal heart rate variability [2], reduced circulating
endothelial progenitor cells [3], increased oxidative stress
[4], and brain-derived neurotrophic factor (BDNF) poly-
morphism [5] have been reported to play a pathogenic role
in RCVS. Recently, reduced cerebral vasomotor reactiv-
ity, which represents cerebral endothelial dysfunction,
was found in seven of eight selected patients with
RCVS in a small retrospective study [6]. However, cere-
bral endothelial dysfunction is also present in migrai-
neurs, especially in the posterior circulation but also in
the anterior circulation in chronic patients [7, 8]. To
identify a disease-specific pattern of cerebral endothe-
lial dysfunction, we aimed to investigate cerebral endo-
thelial function in patients with RCVS compared with
age-matched migraineurs and healthy controls.* Correspondence: cspaul@naver.com†Equal contributors
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We prospectively recruited patients with RCVS within
1 month of onset at the Samsung Medical Center from
April 2015 to July 2016. For the control group, we re-
cruited age-matched patients with episodic migraine
without aura (MOA) and healthy controls, with a 1:1:1
patient-to-control ratio from April 2015 to July 2016.
This study was approved by the Institutional Review
Board in the Samsung Medical Center. All the diagnoses
of RCVS and MOA were based on the third edition of
the International Classification of Headache Disorders
(ICHD-3 beta). Healthy controls did not have any
history of migraine, hypertension, diabetes mellitus,
hyperlipidemia, stroke, cardiac disease, smoking, or the
use of angiotensin II receptor blocker (ARB), angiotensin
converting enzyme inhibitor (ACEi) or statin treatments.
Clinical evaluation
All patients and controls were interviewed by investiga-
tors (HAC, MJL, and C-SC), using a structured headache
questionnaire on the headache characteristics, medical
history, and current medications. For the RCVS group,
neurological complications including focal neurological
deficits, seizure, ischemic stroke, subarachnoid hemorrhage
(SAH), and posterior reversible encephalopathy syndrome
(PRES) were evaluated through clinical observation and
neuroimaging. All patients with RCVS underwent contrast-
enhanced brain magnetic resonance imaging (MRI) and
magnetic resonance angiogram (MRA). Reversibility was
confirmed in all patients with RCVS with a follow-up MRA
3–6 months after symptom onset.
Measurement of cerebral endothelial dysfunction
To determine cerebral endothelial dysfunction, endothelium-
dependent vasodilatory function was measured using trans-
cranial Doppler (TCD) during a breath-holding maneuver.
TCD tests were performed within 1 week of diagnosis
in the RCVS group, between thunderclap headache at-
tacks. For the MOA group, TCD assessment was per-
formed in the interictal period following 48 h without
headache. The TCD evaluation was performed using a
Pioneer TC 8080 (Nicolet Vascular, Madison, WI, USA)
by experienced neurophysiologists who were blinded to
clinical information.
The 2-MHz Doppler hand-held probe was fixed manu-
ally in a supine position. The baseline mean flow velocity
(MFV) of bilateral middle cerebral arteries (MCAs),
posterior cerebral arteries (PCAs), and the basilar artery
(BA) were determined initially. Patients were asked to
hold their breath for 30 s and keep breathing normally
until the initiation of breath-holding procedure to avoid
the Valsalva manoeuver or hyperventilation. Patients who
were unable to hold their breath for the required period
were reassessed up to three times. MFV was thoroughly
monitored and recorded at the end of the 30-s breath-
holding maneuver [9–11]. The breath-holding index
(BHI) was calculated as the % increment of the MFV (i.e.,
[MFV at the end of breath-holding – baseline MFV] x
100/baseline MFV) divided by the duration of the breath-
holding (30 s) [10]. The BHI was determined in bilateral
MCAs, PCAs, and the BA. In the RCVS group, the BHI
measurement was repeated in selected patients after
3 months.
Statistical analyses
Statistical analyses were performed using commercially
available SPSS version 18.0 software (SPSS Inc., Chicago,
IL, USA). Variables were presented as a proportion,
mean ± standard deviation (SD), or a median and inter-
quartile range (IQR). Bivariate analyses were performed
using Student’s t-tests and Mann-Whitney tests for con-
tinuous variables, and Chi-squared and Fisher’s exact
tests for categorical variables. Independent t-tests were
used for the case-control comparison of the MFVs and
BHIs in each vessel. To adjust the baseline flow veloci-
ties, analysis of covariance (ANCOVA) tests were per-
formed to compare the BHIs in each vessel. The mean
BHIs in all tested arteries in each patient was used to
group patients into the higher vs lower mean BHI
subgroups, using the median value as a cutoff. Demo-
graphics, clinical characteristics, and neurologic compli-
cations were compared between the two groups via
linear regression analysis. Two-tailed p-values <0.05
were used to establish a statistical significance.
Results
Baseline demographics of RCVS patients
A total of 34 patients with RCVS were recruited during
the study period. Among them, six patients were excluded,
since they had received treatment with nimodipine (n = 4)
or refused to participate in the study (n = 2). Thus, 28 pa-
tients who completed the TCD assessment per protocol
were included. Age-matched migraineurs and healthy
controls (mean age, 49.8 years; age range, 30–63 years)
were also recruited. The baseline demographics of partici-
pants are presented in Table 1. Patients with RCVS had a
higher frequency of hyperlipidemia (p = 0.004, compared
with healthy control), and thus more of these patients
were currently being treated with statin medication
(p = 0.023; Table 1) at the time of study.
Transcranial doppler findings in RCVS
Patients with RCVS underwent TCD tests at a median of
7.5 (IQR, 4.0–16.5) days after onset. There were no signifi-
cant complications during the breath-holding maneuver.
Patients and healthy controls tolerated the breath hold
well, except one patient who complained of headache.
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Baseline mean flow velocities were higher in the RCVS
group in bilateral MCAs and the BA, compared with
migraineurs (p = 0.059 for the left MCA, p = 0.046 for the
right MCA, and p = 0.016 for the BA; Table 2) and healthy
controls (p = 0.032 for the left MCA, p = 0.041 for the
right MCA, and p = 0.034 for the BA; Table 2). Nine of
twenty-eight patients with RCVS (32.1%) presented in-
creased MFVs in the MCAs that exceeded the upper limit
of the normal range (80 cm/s). Among them, four patients
(14.3%) met the criteria for mild vasospasm (>120 cm/s).
There were no significant differences in the flow velocities
of bilateral PCAs.
All patients of RCVS showed significantly lower
BHIs in basal arteries compared with healthy controls.
In addition, patients with RCVS showed lower BHIs
in the anterior circulation compared to subjects with
episodic MOA (Table 2). Differences in the BHIs
between the RCVS and MOA groups were not signifi-
cant in the posterior circulation, and the results were
generally unchanged after controlling for baseline
MFVs. Similar results were observed even when the
six migraineurs in the RCVS group were excluded
(Additional file 1: Table S1-S2).
Factors related to cerebral endothelial dysfunction in
RCVS
When patients with RCVS were stratified according to a
higher or lower BHIs, vascular risk factors were not as-
sociated with endothelial dysfunction (Table 3). Patients
with lower BHIs were younger and had more migraines
than those with higher BHIs, although statistical signifi-
cance between groups was not reached.
Table 1 Baseline demographics of patients with reversible cerebral vasoconstriction syndrome, migraineurs, and healthy controls
RCVS (N = 28) Migraine (N = 28) Healthy controls
(N = 28)
p-value
vs migrainea vs HCa
Age 49.8 ± 10.08 (30–63) 49.8 ± 10.08 (30–63) 49.8 ± 10.08 (30–63) >0.999 >0.999
Female sex 24 (85.7%) 24 (85.7%) 25 (89.3%) >0.999 >0.999
Diabetes mellitus 4 (14.3%) 0 (0%) 0 (0%) 0.111 0.111
Hypertension 4 (14.3%) 1 (3.6%) 0 (0%) 0.611 0.236
Hyperlipidemia 8 (28.6%) 3 (10.7%) 0 (0%) 0.177 0.004
Stroke 0 (0%) 0 (0%) 0 (0%)
Cardiac disease 1 (3.6%) 0 (0%) 0 (0%) >0.999 >0.999
Smoking 1 (3.6%) 0 (0%) 0 (0%) >0.999 >0.999
Current medication
ARB 1 (3.6%) 0 (0%) 0 (0%) >0.999 >0.999
ACE inhibitor 1 (3.6%) 0 (0%) 0 (0%) >0.999 >0.999
Statin 6 (21.4%) 1 (3.6%) 0 (0%) 0.101 0.023






Thunderclap onset 24 (85.7%)
Triggered by typical precipitants 17 (60.7%)
Recurrent during first 1 month 19 (67.9%)
Neurological complication
Neurological deficits 1 (3.6%)
Seizure 3 (10.7%)
Cerebral infarction 0 (0%)
Cortical SAH 1 (3.6%)
PRES 2 (7.1%)
ACE angiotensin converting enzyme, ARB angiotensin II receptor blocker, PRES posterior reversible encephalopathy syndrome, RCVS reversible cerebral
vasoconstriction syndrome, SAH subarachnoid hemorrhage
Values are presented as number (%), mean ± standard deviation (ranges). acompared with RCVS
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Follow-up evaluation in RCVS
Ten RCVS patients underwent follow-up BHI studies
after 3 months. Follow-up study results showed
complete normalization in seven patients (pre/post,
0.8 ± 0.22/1.3 ± 0.46), while three patients did not
show a significant improvement (no change, n = 2;
aggravation, n = 1) (Fig. 1).
Discussion
The key findings of this article are as follows: (1) cere-
bral endothelial dysfunction is present in patients with
RCVS, (2) the pattern of endothelial dysfunction is more
widespread in RCVS than in migraine, and (3) endothe-
lial dysfunction is reversible in most, but not all patients.
Impaired cerebral endothelial dysfunction may play a
Table 2 Cerebral blood flow velocities and breath-holding indices
RCVS (N = 28) Migraine (N = 28) Healthy controls (N = 28) p-value (adjusted p)
vs migrainea vs HCa
Mean flow velocities (cm/s)
L MCA 76.4 ± 28.56 64.2 ± 11.20 62.5 ± 10.47 0.059 0.032
R MCA 78.4 ± 28.05 65.9 ± 14.04 66.1 ± 10.32 0.046 0.041
L PCA 38.6 ± 10.75 36.5 ± 6.65 37.4 ± 6.58 0.410 0.617
R PCA 39.4 ± 11.29 36.8 ± 6.36 38.8 ± 7.14 0.341 0.906
BA 54 ± 13.61 46.7 ± 5.98 46.5 ± 10.65 0.016 0.034
Breath-holding index
L MCA 0.8 ± 0.33 1.1 ± 0.34 1.2 ± 0.24 0.002 (0.004) <0.001 (<0.001)
R MCA 1.0 ± 0.36 1.3 ± 0.52 1.3 ± 0.39 0.038 (0.109) 0.009 (0.033)
L PCA 0.8 ± 0.42 1.0 ± 0.38 1.3 ± 0.43 0.069 (0.160) <0.001 (<0.001)
R PCA 1.0 ± 0.42 1.1 ± 0.34 1.3 ± 0.49 0.247 (0.375) 0.028 (0.090)
BA 0.9 ± 0.47 1.0 ± 0.42 1.1 ± 0.31 0.120 (0.178) 0.060 (0.031)
BA basilar artery, HC, healthy control, MCA middle cerebral artery, PCA posterior cerebral artery, RCVS reversible cerebral vasoconstriction syndrome
Values are presented as mean ± standard deviation. acompared with RCVS
Adjustment of flow velocities were performed to compare breath holding indices in each vessel
Table 3 Factors related to cerebral endothelial dysfunction in RCVS
Low BHI (N = 14) High BHI (N = 14) P-value
Age 46.9 ± 10.93 (30–60) 52.7 ± 8.55 (35–63) 0.126
Female sex 13 (92.9%) 11 (78.6%) 0.297
Diabetes mellitus 2 (14.3%) 2 (14.3%) >0.999
Hypertension 1 (7.1%) 2 (14.3%) 0.558
Hyperlipidemia 5 (35.7%) 3 (21.4%) 0.422
Stroke 0 (0%) 0 (0%)
Cardiac disease 1 (7.1%) 0 (0%) 0.327
Smoking 0 (0%) 1 (7.1%) 0.327
Current medication
ARB 0 (0%) 1 (7.1%) 0.276
ACE inhibitor 1 (7.1%) 0 (0%) 0.385
Statin 2 (14.3%) 4 (28.6%) 0.376
History of migraine 5 (35.7%) 1 (7.1%) 0.069
Causes of RCVS 0.297
Idiopathic 11 (78.6%) 13 (92.9%)
Postpartum 3 (21.4%) 1 (7.1%)
Medication 0 (0%) 0 (0%)
ACE angiotensin converting enzyme, ARB angiotensin II receptor blocker, RCVS
reversible cerebral vasoconstriction syndrome
Values are presented as number (%), mean ± standard deviation (ranges)
Fig. 1 Baseline and follow-up breath holding indices in patients and
matched controls Breath holding index (BHI) of all tested vessels was
averaged. The follow-up study showed a complete normalization in
seven patients, no change in two, and aggravation in one patient
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role in the pathophysiology of RCVS; its role in predis-
position should be determined in future researches.
The endothelium, which comprises the innermost
layer of the vessel wall, is a key mediator of vascular
tone since it controls vasoconstriction and vasodilation
[12]. Endothelial cell function can be assessed in two
manners. One method of assessment is measuring circu-
lating markers of endothelial cell activation, injury, or re-
pair [12, 13]. In a recent study, Chen et al. [3] reported a
reduced number of circulating markers that is respon-
sible for endothelial cell repair in patients with RCVS.
The other method of measuring endothelial cell function
is the assessment of endothelium-dependent vasomotion
[12]. Unlike circulating markers, endothelium-dependent
vasomotion can be measured differently in systemic and
cerebral circulation. Cerebral vasomotor reactivity is a
method that specifically measures endothelium-dependent
vasodilation in cerebral circulation, which may differ from
systemic endothelial function [14, 15]. Our findings
confirm that endothelium-dependent vasodilation is
impaired in the cerebral arteries of patients with
RCVS. Along with the findings of cardiac involvement
in RCVS [15], future research should focus on the
correlation or difference between cerebral and sys-
temic endothelial dysfunction in RCVS.
Breath holding is a physiologic and reliable method to
induce endothelium-dependent vasodilation in cerebral ar-
teries in response to arterial carbon dioxide levels [10, 16].
The BHI is calculated using the % increment of post-
breath-holding MFVs compared to baseline MFVs. In the
present study, patients with RCVS showed significantly re-
duced BHIs in all basal arteries, implying clinical signifi-
cance of impaired endothelium-dependent vasodilation in
RCVS. There was, however, not a great difference in the
posterior circulation in RCVS compared with episodic
MOA. Cerebral endothelial dysfunction in the posterior
circulation has been consistently reported in migraine [8].
Two hypotheses can explain the differences in the distri-
bution of cerebral endothelial dysfunction between RCVS
and migraine. First, endothelial function may be systemic-
ally impaired in patients with RCVS to a greater extent
than that in migraineurs [3, 14, 15]. Second, as the poster-
ior circulation is less innervated with sympathetic fibers
than the anterior circulation [17], both sympathetic and
parasympathetic dysfunction may play a role in the patho-
physiology of RCVS [2].
Our study showed that endothelial dysfunction in RCVS
is not related to advanced age, vascular risk factors, or pre-
morbid medications. Rather, younger age and premorbid
migraine were associated with more severe endothelial dys-
function, although statististically insignificant. However, it is
still not clear if cerebral endothelial dysfunction is a predis-
position of RCVS or a part of its pathophysiology. Although
our study was not longitudinally designed, our limited data
showed a normalization of endothelial dysfunction in some
patients. However, endothelial dysfunction was persistent
or even aggravated in a small number of patients,
suggesting either poor treatment outcome or premor-
bid endothelial dysfunction. Future studies should be
designed to determine whether endothelial dysfunc-
tion is a predisposition for RCVS or not. In addition,
other predisposing factors such as genetic poly-
morphism should be considered in association with
endothelial dysfunction [5].
This study has strengths. First, this is a prospective
case-control study that included RCVS, migraine, and
healthy control subjects. Confounding factors that might
affect cerebral microvasculature were thoroughly investi-
gated and controlled for in the analysis. Second, we
selectively measured cerebral-specific endothelial func-
tion in RCVS. Third, we made several hypotheses re-
garding the pathogenesis of RCVS. However, this study
has some limitations. First, this study was performed in
a single ethnic population, i.e. Asians. Our study subjects
had a small number of neurological complications,
which might be attributed to the study population. Ex-
ternal validation is warranted in different populations.
Second, we did not evaluate concurrent systemic endothe-
lial dysfunction in comparison to the BHI. It would be
worthwhile to test the correlation or difference between
systemic endothelial dysfunction (i.e. flow-mediated dila-
tation) and the BHI in future studies.
Conclusions
In conclusion, our results suggest that cerebral endothe-
lial function is impaired in patients with RCVS in a
widespread pattern. Future investigations should be con-
ducted to reveal differences in systemic and cerebral
endothelial function and the implications of endothelial
dysfunction in the pathogenesis and neurological out-
comes of patients with RCVS.
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